Have a personal or library account? Click to login
Histamine and its Effects Mediated via H3 Receptor – Potential Clinical Applications of H3 Antagonists Cover

Histamine and its Effects Mediated via H3 Receptor – Potential Clinical Applications of H3 Antagonists

By: E. Hanuskova and  J. Plevkova  
Open Access
|May 2013

References

  1. 1. White MV. The role of histamine in allergic diseases. J allergy Clin Immunol 1990; 57: 599-605.10.1016/S0091-6749(05)80223-4
  2. 2. Greaves MW, Sabroe RU. Allergy and the skin. I - Urticaria Br Med J 1998;57:1147-1150.
  3. 3. Friedmann PS. Assessment of urticaria and angio-oedema. Clin Exp Allergy 1999; 57: 109-112.10.1046/j.1365-2222.1999.0290s3109.x
  4. 4. Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009; 39: 1786-1800.10.1111/j.1365-2222.2009.03374.x
  5. 5. Dale HH, Laidlaw PP. The physiological action of beta-imidazolylethylamine. J Physiol 1910; 41: 318-344.10.1113/jphysiol.1910.sp001406
  6. 6. Dale HH, Laidlaw PP. Histamine shock. J Physiol. 1919; 52: 355-390.10.1113/jphysiol.1919.sp001837
  7. 7. Popielski L. -Imidazolylathylamin und die Organextrakte Erster Teil: -Imidazolylathylamin als mechtiger Errezer der Magendrucken. Pfluegers Arch 1920; 178: 214-236.10.1007/BF01722024
  8. 8. Lewis T., Grant T. Vascular reactions of the skin to injury. Part 11. The liberation of histamine - like substance in the injured skin, the underlying cause of factitious urticaria and of wheals produced by burning: and observations upon the nervous control of certain skin reactions. Heart 1924; 11: 209-265.
  9. 9. Steinhoff M, Griffiths C, Church M, Lugar TA. Histamine. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Oxford, United Kingdom: Blackwell Science, 2004: 9. p. 50-52.
  10. 10. Best CH., Dale HH., Dudey HW, Thorpe WV. The nature of the vasodilator constituents of certain tissues. J Physiol 1927; 62: 397.10.1113/jphysiol.1927.sp002369
  11. 11. Endo Y. Simultaneous induction of histidine and ornithinedecarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide intomice. Biochem Pharmacol 1982; 31:1643-1647.10.1016/0006-2952(82)90394-X
  12. 12. Szeberényi JB, Pállinger E, Zsinkó M, Pós Z, Rothe G, Orsó E, Szeberényi S, Schmitz G, Falus A, László V. Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001; 76: 175-182.10.1016/S0165-2478(01)00184-5
  13. 13. Radvány Z, Darvas Z, Kerekes K, Prechl J, Szalai C, Pállinger E, Valéria L, Varga VL, Sandor M, Erdei A, Falus A. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murineTcells. SeminCancer Biol 2000; 10: 41-45.10.1006/scbi.2000.030610888270
  14. 14. Shiraishi M, Hirasawa N, Oikawa S, Kobayashi Y, Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000; 99:600-606.10.1046/j.1365-2567.2000.00986.x
  15. 15. Maslinski C, Fogel WA. Catabolism of Histamine. In: Uvnäs B, editor. Handbook of experimental pharmacology. Histamine and histamine antagonists. Berlin-Heidelberg: Springer; 1991. P. 165-189.10.1007/978-3-642-75840-9_14
  16. 16. Schwelberger HG, Hittmair A, Kohlwein SD. Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm Res 1998; 47 Suppl 1: S60-1.10.1007/s000110050273
  17. 17. Schwelberger HG, Bodner E. Purification and characterization of diamineoxidase from porcine kidney and intestine. Biochim Biophys Acta 1997; 1340: 152-164.10.1016/S0167-4838(97)00039-3
  18. 18. Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht CD, Feussner KD. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta 1983; 756: 196-203.10.1016/0304-4165(83)90092-2
  19. 19. Raithel M, Kufner M, Ulrich P, Hahn EG. The involvement of the histamine degradation pathway by diamineoxidase in manifest gastrointestinal allergies. Inflamm Res 1999; 48 Suppl 1: S75-76.10.1007/s000110050414
  20. 20. Klocker J, Matzler SA, Huetz GN, Drasche A, Kolbitsch C, Schwelberger HG. Expression of histamine degrading enzymes in porcine tissues. Inflamm Res 2005; 54(suppl): S54-57.10.1007/s00011-004-0425-7
  21. 21. Brown DD, Tomchick R, Axelrod J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem 1959; 234: 2948-2950.10.1016/S0021-9258(18)69701-7
  22. 22. Kufner MA, Ulrich P, Raithel M, Schwelberger HG. Determination of histamine degradation capacity in extremely small human colon samples. Inflamm Res 2001; 50(suppl): S96-97.10.1007/PL00022422
  23. 23. Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, editor. Histamine: biology and medical aspects. Budapest, Hungary: Spring Med Publishing; 2004. p. 53-59. 24 Yamauchi K, Sekizawa K, Suzuki H, Nakazawa H, Ohkawara Y, Katayose D, Ohtsu H, Tamura G, Shibahara S, Takemura M, et al. Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol 1994; 267(3 Pt 1): L342-349.10.1152/ajplung.1994.267.3.L3427943261
  24. 25. Vlieg-BoerstraBJ, van der HeideS, Oude Elberink JN, Kluin-Nelemans JC, Dubois AE. Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med 2005; 63: 244-249.
  25. 26. Ring J. Angewandte Allergologie. (Implemented allergology.) Munich, Germany: Urban & Vogel; 2004.
  26. 27. White MV, Slater J, Kaliner M. Histamine and asthma. Am Rev Respir Dis 1987; 57: 1165-1176.
  27. 28. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007; 85: 1185-1196.10.1093/ajcn/85.5.118517490952
  28. 29. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem. 2000; 275:36781-3676.10.1074/jbc.M006480200
  29. 30. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279: 615-620.10.1006/bbrc.2000.4008
  30. 31. Milligan G, Bond RA, Lee M.Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 1995; 16:10-13.
  31. 32. Ash AS, Schild HO. Receptors mediating some actions of histamine. 1966. Br J Pharmacol. 1997;120(4 Suppl): 302-314, discussion 300-301.
  32. 33. Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. A potent and selective histamine H4 receptor antagonist with antiinflammatory properties. J Pharmacol Exp Ther 2004; 309: 404-413.10.1124/jpet.103.061754
  33. 34. LaBella FS, Queen GM, Brandes LJ. Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs. J Cell Biochem 2000; 76: 686-694.10.1002/(SICI)1097-4644(20000315)76:4<;686::AID-JCB16>3.0.CO;2-V
  34. 35. Brandes LJ, Queen GM, LaBella FS. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isoenzymes that metabolize antineoplastic drugs. Cancer ChemotherPharmacol.2000; 45: 298-304.10.1007/s002800050044
  35. 36. Paesen GC, Adams PL, Harlos K, Nuttall PA, Stuart DI. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol Cell 1999; 3: 661-671.10.1016/S1097-2765(00)80359-7
  36. 37. Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol 2011; 106 (2 Suppl): 2-5.10.1016/j.anai.2010.08.005
  37. 38. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302: 832-837.10.1038/302832a0
  38. 39. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG. Cloning and Functional Expression of the Human Histamine H3 Receptor Mol Pharmacol 1999; 55: 1101-1107.
  39. 40. Bongers G, Bakker RA, Leurs R. Molecular aspects of the histamine H3 receptor. Biochem Pharmacol 2007; 73: 1195-1204.10.1016/j.bcp.2007.01.008
  40. 41. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H, Panula P, Leurs R. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 2001; 59: 1-8.10.1124/mol.59.1.1
  41. 42. Tardivel-Lacombe J, Rouleau A, Héron A, Morisset S, Pillot C, Cochois V, Schwartz JC, Arrang JM. Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms.Neuroreport.2000;11:755-75910.1097/00001756-200003200-00020
  42. 43. Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C, Lord B, Mazur C, Kamme F, Nishino S, Carruthers N, Lovenberg T. Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 2007; 73: 1084-1096.10.1016/j.bcp.2006.10.031
  43. 44. Sander K, Kottke T, Stark H. Histamine H3 receptor antagonists go to clinics. Biol Pharm Bull 2008; 31: 2163-2181.10.1248/bpb.31.2163
  44. 45. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63: 637-672.10.1016/S0301-0082(00)00039-3
  45. 46. Zhang M, Venable JD, Thurmond RL. The histamine H4 receptor in autoimmune disease. Expert Opin Investig Drugs 2006; 15: 1443-1452.10.1517/13543784.15.11.144317040202
  46. 47. Yu F, Bonaventure P, Thurmond RL. The Future Antihistamines: Histamine H(3) and H(4) Receptor Ligands. Adv Exp Med Biol 2010; 709: 125-140.10.1007/978-1-4419-8056-4_1221618893
  47. 48. Tiligada E, Zampeli E, Sander K, Stark H. Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 2009; 18: 1519-1531.10.1517/1472822090318843819758107
  48. 49. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000; 20: 131-147.10.1023/A:1007074420772
  49. 50. Hough LB, Rice FL, H3 receptors and painmodulation: peripheral, spinal, and brain interactions. J Pharmacol Exp Ther 2011; 336: 30-37.10.1124/jpet.110.171264301429820864501
  50. 51. Coruzzi G, Poli E, Morini G, Bertaccini G. The Histamine H3 Receptor. In Molecular Targets for Drug Development: GI Diseases. TS Gaginella, A Guglietta, editors. Totowa, NJ: Humana Press; 2000. p. 239-267.10.1007/978-1-59259-202-9_9
  51. 52. Coruzzi G, Morini G, Adami M, Grandi D. Role of histamine H3 receptors in the regulation of gastric functions. J Physiol Pharmacol 2001; 52(4 Pt 1): 539-553.
  52. 53. Imamura M, Seyedi N, Lander HM, Levi R. Functional identification of histamine H3-receptors in the human heart. Circ Res 1995; 77: 206-210.10.1161/01.RES.77.1.206
  53. 54. Hashikawa-Hobara N, Chan NY, Levi R. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart. J Pharmacol Exp Ther 2012; 340:185-191.10.1124/jpet.111.187765
  54. 55. Gruber BL. Mastcells and basophils. In: Sigal LH, Ron Y, editors. Immunology and inflammation: basic mechanisms and clinical consequences New York: McGraw-Hill; 1994. p. 337-351.
  55. 56. Suzuki S, Takeuchi K, Majima Y. Localization and function of histamine H3 receptor in the nasal mucosa. Clin Exp Allergy 2008; 38: 1476-1482.10.1111/j.1365-2222.2008.03041.x
  56. 57. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol. 2004; 113: 552-557.10.1177/000348940411300707
  57. 58. Varty LM, Gustafsoo E, Laverty M, Hey JA. Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 2004; 484: 83-89.10.1016/j.ejphar.2003.10.051
  58. 59. Ichinose M, Barnes PJ. Inhibitory histamine H3-receptors on cholinergic nerves in humana airways. Eur J Pharmaco1 1989; 163: 383-386.10.1016/0014-2999(89)90212-4
  59. 60. Ichinose M, Stretton C D, SchwaftzJ C, Barnes PJ. Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br J Pharmacol 1989; 97: 13-1510.1111/j.1476-5381.1989.tb11917.x18544832541854
  60. 61. Dimitriadou V, Rouleau A, Dam Trung Tuong M, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M. Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen. Clin Sci (Lond) 1994; 87: 151-163 10.1042/cs08701517924160
DOI: https://doi.org/10.2478/acm-2013-0004 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Language: English
Page range: 28 - 36
Published on: May 9, 2013
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year

© 2013 E. Hanuskova, J. Plevkova, published by Sciendo
This work is licensed under the Creative Commons License.